Drawing for ARYTHA BIOSCIENCES

USPTO serial 85644122

ARYTHA BIOSCIENCES

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
SPRUILL, DARRYL M
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ARYTHA BIOSCIENCES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Veterinary preparations for the treatment of bird and mammal diseases, disorders, or physiological or pathological conditions, namely, infectious diseases, parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, disorders involving the immune mechanism, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye and adnexam, diseases of the ear and mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, congenital malformations, deformations, conditions originating in the perinatal period, chromosomal abnormalities, injuries, poisoning, consequences of external causes, and external causes of morbidity and mortality; veterinary preparations for use during bird and mammal pregnancy and birth; pharmaceuticals preparations for the treatment of diseases, disorders, or physiological or pathological conditions, namely, infectious diseases, parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, disorders involving the immune mechanism, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye and adnexam, diseases of the ear and mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, congenital malformations, deformations, conditions originating in the perinatal period, chromosomal abnormalities, injuries, poisoning, consequences of external causes, and external causes of morbidity and mortality; pharmaceuticals preparations for use during pregnancy, childbirth and the puerperium; diagnostic reagents and preparations for medical or veterinary purposes; vaccinesACTIVE
010Medical and diagnostic devices for magnetic resonance imaging, radiography, nuclear imaging, tomography, photoacoustic imaging, ultrasound, echocardiography, and fluorescence imagingACTIVE
042Pharmaceutical research and development services; research and development in the pharmaceutical and biotechnology fields; providing reagent sample testing and diagnostic services for others in the fields of science and research related theretoACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 18, 2014MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 17, 2014ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 16, 2013NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 21, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 1, 2013NPUBNOTICE OF PUBLICATION
Apr 18, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 18, 2013ALIEASSIGNED TO LIE
Mar 26, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Mar 26, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Mar 25, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 25, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 24, 2012CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 21, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 20, 2012DOCKASSIGNED TO EXAMINER
Jun 16, 2012MDSCNOTICE OF DESIGN SEARCH CODE MAILED
Jun 15, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 8, 2012NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance